Drugs containing reduced of vitamin B 2

Details Drugs containing reduced of vitamin B 2 Drugs containing reduced of vitamin B 2

2002-03-19

2009-08-25

Kim, Jennifer Myong M (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C514S250000, C514S081000

Reexamination Certificate

active

07579325

ABSTRACT:
The present invention provides medicines for preventing or treating infectious diseases, sepsis and/or septic shock, which exhibit excellent immunostimulating effects. More specifically, the invention provides medicines for immunostimulation and infection-protection and -treatment, and/or for preventing or treating sepsis and septic shock, which comprise reduced riboflavin and/or reduced riboflavin derivative or pharmacologically acceptable salt thereof. Also provided are methods for using them in the prevention and/or treatment of infectious disorders such as sepsis and septic shock.

REFERENCES:
patent: 2970995 (1961-02-01), Wheeler
patent: 4956381 (1990-09-01), Bollinger et al.
patent: 5334510 (1994-08-01), Usui et al.
patent: 5714469 (1998-02-01), DeMarsh
patent: 5814632 (1998-09-01), Araki et al.
patent: 5945420 (1999-08-01), Araki et al.
patent: 2003/0143265 (2003-07-01), Araki et al.
patent: 2003/0161871 (2003-08-01), Hird et al.
patent: 2003/0162751 (2003-08-01), Grobin et al.
patent: 4328871 (1995-03-01), None
patent: 319463 (1989-06-01), None
patent: 319463 (1989-06-01), None
patent: 531708 (1993-03-01), None
patent: 578733 (1994-01-01), None
patent: 679398 (1995-11-01), None
patent: 1-146819 (1989-06-01), None
patent: 5-64597 (1993-03-01), None
patent: 5-201864 (1993-08-01), None
patent: 6-506212 (1994-07-01), None
patent: 9-301861 (1997-11-01), None
patent: 10-29941 (1998-02-01), None
patent: 11-199486 (1999-07-01), None
patent: 11-199513 (1999-07-01), None
patent: 2000-80046 (2000-03-01), None
patent: 2000-178246 (2000-06-01), None
patent: 2000-297046 (2000-10-01), None
patent: 2000-297049 (2000-10-01), None
patent: 2000-302768 (2000-10-01), None
patent: WO 92/17173 (1992-10-01), None
patent: WO 93/05784 (1993-04-01), None
patent: WO 95/22898 (1995-02-01), None
patent: WO 95/05852 (1995-03-01), None
patent: WO 97/36594 (1997-10-01), None
patent: WO 02/03972 (2002-01-01), None
Lahnborg et al. Efficacy of tinidazole compared to clindamycin in the treatment of experimentally induced intra-abdominal sepsis. The Birtish socciety for Antimicrobial Chemotherapy. 1982; 10 (suppl. a); pp. 117-121.
U.S. Appl. No. 10/145,006, filed May 14, 2002, Hird et al.
Akompong T. et al., “In Vitro Activity of Riboflavin against the Human Malaria ParasitePlasmodium falciparum”, Antimicrobial Agents and Chemotherapy, 2000, 44(1), 88-96.
International Search Report issued for corresponding PCT application PCT/JP02/02616 (WO 02/074313). 2002.
Liu et al. “Effect of NADH on Immunological Cells in the Peripheral Blood After Radiation”Mianyixue Zazhi Bianjibu(2001) 17:444-445 and 448 (Chemical Abstract).
Xu and Hultquist, “Coupling of Dihydroriboflavin Oxidation to the Formation of the Higher Valence States of Hemeproteins,”Biochemical and Biophysical Research Communications(1991) 181:197-203.

Affiliated with

Also associated with

Rating

Drugs containing reduced of vitamin B 2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drugs containing reduced of vitamin B 2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drugs containing reduced of vitamin B 2 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4078501